Biotechnology Fund Class Fund Manager Performance Evaluation
| RYCFX Fund | USD 44.16 0.65 1.45% |
The fund shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Biotechnology Fund are completely uncorrelated.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Biotechnology Fund Class are ranked lower than 13 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak technical and fundamental indicators, Biotechnology Fund showed solid returns over the last few months and may actually be approaching a breakup point.
...more| Expense Ratio Date | 1st of August 2025 | |
| Expense Ratio | 2.3800 |
Biotechnology |
Biotechnology Fund Relative Risk vs. Return Landscape
If you would invest 3,195 in Biotechnology Fund Class on October 31, 2025 and sell it today you would earn a total of 1,221 from holding Biotechnology Fund Class or generate 38.22% return on investment over 90 days. Biotechnology Fund Class is currently producing 0.5973% returns and takes up 3.6361% volatility of returns over 90 trading days. Put another way, 32% of traded mutual funds are less volatile than Biotechnology, and 88% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Biotechnology Fund Current Valuation
Fairly Valued
Today
Please note that Biotechnology Fund's price fluctuation is very steady at this time. At this time, the entity appears to be fairly valued. Biotechnology Fund Class shows a prevailing Real Value of $44.23 per share. The current price of the fund is $44.16. We determine the value of Biotechnology Fund Class from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we favor acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will blend.
Since Biotechnology Fund is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biotechnology Mutual Fund. However, Biotechnology Fund's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 44.16 | Real 44.23 | Hype 29.5 | Naive 45.73 |
The intrinsic value of Biotechnology Fund's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Biotechnology Fund's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Biotechnology Fund Class helps investors to forecast how Biotechnology mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biotechnology Fund more accurately as focusing exclusively on Biotechnology Fund's fundamentals will not take into account other important factors: Biotechnology Fund Target Price Odds to finish over Current Price
The tendency of Biotechnology Mutual Fund price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 44.16 | 90 days | 44.16 | about 12.1 |
Based on a normal probability distribution, the odds of Biotechnology Fund to move above the current price in 90 days from now is about 12.1 (This Biotechnology Fund Class probability density function shows the probability of Biotechnology Mutual Fund to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Biotechnology Fund has the beta coefficient that is very close to zero indicating the returns on DOW JONES INDUSTRIAL and Biotechnology Fund do not appear to be sensitive. Additionally It does not look like Biotechnology Fund's alpha can have any bearing on the current valuation. Biotechnology Fund Price Density |
| Price |
Predictive Modules for Biotechnology Fund
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Biotechnology Fund Class. Regardless of method or technology, however, to accurately forecast the mutual fund market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the mutual fund market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Biotechnology Fund Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Biotechnology Fund is not an exception. The market had few large corrections towards the Biotechnology Fund's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Biotechnology Fund Class, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Biotechnology Fund within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 5.53 | |
Ir | Information ratio | 0.15 |
Biotechnology Fund Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Biotechnology Fund for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Biotechnology Fund Class can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Biotechnology Fund appears to be risky and price may revert if volatility continues | |
| Latest headline from news.google.com: Redevco buys first German asset for retail parks fund - Green Street News | |
| The fund maintains 99.51% of its assets in stocks |
Biotechnology Fund Fundamentals Growth
Biotechnology Mutual Fund prices reflect investors' perceptions of the future prospects and financial health of Biotechnology Fund, and Biotechnology Fund fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biotechnology Mutual Fund performance.
| Price To Earning | 21.12 X | ||||
| Price To Book | 3.27 X | ||||
| Price To Sales | 4.45 X | ||||
| Total Asset | 490 K | ||||
About Biotechnology Fund Performance
Evaluating Biotechnology Fund's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Biotechnology Fund has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Biotechnology Fund has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Under normal circumstances, the fund invests substantially all of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The fund is non-diversified.Things to note about Biotechnology Fund Class performance evaluation
Checking the ongoing alerts about Biotechnology Fund for important developments is a great way to find new opportunities for your next move. Mutual Fund alerts and notifications screener for Biotechnology Fund Class help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Biotechnology Fund appears to be risky and price may revert if volatility continues | |
| Latest headline from news.google.com: Redevco buys first German asset for retail parks fund - Green Street News | |
| The fund maintains 99.51% of its assets in stocks |
- Analyzing Biotechnology Fund's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biotechnology Fund's stock is overvalued or undervalued compared to its peers.
- Examining Biotechnology Fund's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biotechnology Fund's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biotechnology Fund's management team can help you assess the Mutual Fund's leadership.
- Pay attention to analyst opinions and ratings of Biotechnology Fund's mutual fund. These opinions can provide insight into Biotechnology Fund's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Fund financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Fund security.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |